Some patients with an acute large-vessel ischemic stroke who already show a large-core infarct at early imaging can still benefit from thrombectomy, especially if the procedure successfully restores ...
A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...
Current treatment of acute stroke focuses on administration of lytic medications and endovascular techniques meant to restore blood flow quickly in order to decrease the volume of irreversible tissue ...
In patients with acute stroke and a large infarct of unrestricted size, thrombectomy and medical care led to better functional outcomes and lower mortality compared with medical care alone, the ...
Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced its participation in the American Society for Experimental ...
Approval marks Harrison.ai's second out of three Breakthrough designations to reach marketing authorization, and 9th FDA clearance covering a total of 13 radiological findings.SYDNEY & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results